MX2008013796A - Biomarcadores de infeccion por el virus de hepatitis c. - Google Patents

Info

Publication number

MX2008013796A

MX2008013796A MX2008013796A MX2008013796A MX2008013796A MX 2008013796 A MX2008013796 A MX 2008013796A MX 2008013796 A MX2008013796 A MX 2008013796A MX 2008013796 A MX2008013796 A MX 2008013796A MX 2008013796 A MX2008013796 A MX 2008013796A

Authority

MX

Mexico

Prior art keywords

activity

gene

protein

subject

hepatitis

Prior art date

2006-04-26

Links

• Espacenet
• Global Dossier
• Discuss

• 208000010710 hepatitis C virus infection Diseases 0.000 title claims abstract description 36
• 239000000090 biomarker Substances 0.000 title description 4
• 108090000623 proteins and genes Proteins 0.000 claims abstract description 439
• 238000000034 method Methods 0.000 claims description 228
• 241000711549 Hepacivirus C Species 0.000 claims description 209
• 230000014509 gene expression Effects 0.000 claims description 180
• 102000014150 Interferons Human genes 0.000 claims description 157
• 108010050904 Interferons Proteins 0.000 claims description 157
• 229940079322 interferon Drugs 0.000 claims description 142
• 238000011282 treatment Methods 0.000 claims description 135
• 108010017101 telaprevir Proteins 0.000 claims description 126
• 229960002935 telaprevir Drugs 0.000 claims description 125
• 208000015181 infectious disease Diseases 0.000 claims description 83
• 230000008569 process Effects 0.000 claims description 67
• 101001082060 Homo sapiens Interferon-induced protein with tetratricopeptide repeats 3 Proteins 0.000 claims description 62
• 102100027302 Interferon-induced protein with tetratricopeptide repeats 3 Human genes 0.000 claims description 62
• YMZPQKXPKZZSFV-CPWYAANMSA-N 2-[3-[(1r)-1-[(2s)-1-[(2s)-2-[(1r)-cyclohex-2-en-1-yl]-2-(3,4,5-trimethoxyphenyl)acetyl]piperidine-2-carbonyl]oxy-3-(3,4-dimethoxyphenyl)propyl]phenoxy]acetic acid Chemical compound C1=C(OC)C(OC)=CC=C1CC[C@H](C=1C=C(OCC(O)=O)C=CC=1)OC(=O)[C@H]1N(C(=O)[C@@H]([C@H]2C=CCCC2)C=2C=C(OC)C(OC)=C(OC)C=2)CCCC1 YMZPQKXPKZZSFV-CPWYAANMSA-N 0.000 claims description 55
• 239000003112 inhibitor Substances 0.000 claims description 51
• 230000002068 genetic effect Effects 0.000 claims description 50
• 239000000137 peptide hydrolase inhibitor Substances 0.000 claims description 47
• 230000004044 response Effects 0.000 claims description 47
• 229940124158 Protease/peptidase inhibitor Drugs 0.000 claims description 44
• -1 IFI3 Proteins 0.000 claims description 42
• 101000840275 Homo sapiens Interferon alpha-inducible protein 27, mitochondrial Proteins 0.000 claims description 41
• 102100029604 Interferon alpha-inducible protein 27, mitochondrial Human genes 0.000 claims description 41
• GXAFMKJFWWBYNW-OWHBQTKESA-N 2-[3-[(1r)-1-[(2s)-1-[(2s)-3-cyclopropyl-2-(3,4,5-trimethoxyphenyl)propanoyl]piperidine-2-carbonyl]oxy-3-(3,4-dimethoxyphenyl)propyl]phenoxy]acetic acid Chemical compound C1=C(OC)C(OC)=CC=C1CC[C@H](C=1C=C(OCC(O)=O)C=CC=1)OC(=O)[C@H]1N(C(=O)[C@@H](CC2CC2)C=2C=C(OC)C(OC)=C(OC)C=2)CCCC1 GXAFMKJFWWBYNW-OWHBQTKESA-N 0.000 claims description 40
• 101001082058 Homo sapiens Interferon-induced protein with tetratricopeptide repeats 2 Proteins 0.000 claims description 40
• 102100027303 Interferon-induced protein with tetratricopeptide repeats 2 Human genes 0.000 claims description 40
• 101001034844 Homo sapiens Interferon-induced transmembrane protein 1 Proteins 0.000 claims description 38
• 102100040021 Interferon-induced transmembrane protein 1 Human genes 0.000 claims description 38
• 102100031802 Interferon-induced GTP-binding protein Mx1 Human genes 0.000 claims description 37
• 101001128393 Homo sapiens Interferon-induced GTP-binding protein Mx1 Proteins 0.000 claims description 36
• 239000003814 drug Substances 0.000 claims description 35
• 101001067396 Homo sapiens Phospholipid scramblase 1 Proteins 0.000 claims description 34
• 102100034627 Phospholipid scramblase 1 Human genes 0.000 claims description 34
• 102100035389 2'-5'-oligoadenylate synthase 3 Human genes 0.000 claims description 32
• 101100519283 Arabidopsis thaliana PDX13 gene Proteins 0.000 claims description 32
• 101150099040 GIP2 gene Proteins 0.000 claims description 32
• 101100218339 Gibberella zeae (strain ATCC MYA-4620 / CBS 123657 / FGSC 9075 / NRRL 31084 / PH-1) aurR1 gene Proteins 0.000 claims description 32
• 101000597332 Homo sapiens 2'-5'-oligoadenylate synthase 3 Proteins 0.000 claims description 32
• 229940079593 drug Drugs 0.000 claims description 32
• 230000028993 immune response Effects 0.000 claims description 28
• 230000004547 gene signature Effects 0.000 claims description 27
• 238000011156 evaluation Methods 0.000 claims description 24
• 101000840293 Homo sapiens Interferon-induced protein 44 Proteins 0.000 claims description 23
• 102100029607 Interferon-induced protein 44 Human genes 0.000 claims description 23
• 230000002459 sustained effect Effects 0.000 claims description 23
• 102100040225 Gamma-interferon-inducible lysosomal thiol reductase Human genes 0.000 claims description 22
• 102100039928 Gamma-interferon-inducible protein 16 Human genes 0.000 claims description 22
• 101001037132 Homo sapiens Gamma-interferon-inducible lysosomal thiol reductase Proteins 0.000 claims description 22
• 101000960209 Homo sapiens Gamma-interferon-inducible protein 16 Proteins 0.000 claims description 22
• 101001034842 Homo sapiens Interferon-induced transmembrane protein 2 Proteins 0.000 claims description 22
• 101001034846 Homo sapiens Interferon-induced transmembrane protein 3 Proteins 0.000 claims description 22
• 102100040020 Interferon-induced transmembrane protein 2 Human genes 0.000 claims description 22
• 102100040035 Interferon-induced transmembrane protein 3 Human genes 0.000 claims description 22
• 230000003612 virological effect Effects 0.000 claims description 22
• 101000998500 Homo sapiens Interferon-induced 35 kDa protein Proteins 0.000 claims description 21
• 102100033273 Interferon-induced 35 kDa protein Human genes 0.000 claims description 21
• 101001082063 Homo sapiens Interferon-induced protein with tetratricopeptide repeats 5 Proteins 0.000 claims description 18
• 101000657037 Homo sapiens Radical S-adenosyl methionine domain-containing protein 2 Proteins 0.000 claims description 18
• 102100027356 Interferon-induced protein with tetratricopeptide repeats 5 Human genes 0.000 claims description 18
• 102100033749 Radical S-adenosyl methionine domain-containing protein 2 Human genes 0.000 claims description 18
• 230000000840 anti-viral effect Effects 0.000 claims description 18
• GTVAUHXUMYENSK-RWSKJCERSA-N 2-[3-[(1r)-3-(3,4-dimethoxyphenyl)-1-[(2s)-1-[(2s)-2-(3,4,5-trimethoxyphenyl)pent-4-enoyl]piperidine-2-carbonyl]oxypropyl]phenoxy]acetic acid Chemical compound C1=C(OC)C(OC)=CC=C1CC[C@H](C=1C=C(OCC(O)=O)C=CC=1)OC(=O)[C@H]1N(C(=O)[C@@H](CC=C)C=2C=C(OC)C(OC)=C(OC)C=2)CCCC1 GTVAUHXUMYENSK-RWSKJCERSA-N 0.000 claims description 17
• 101001082065 Homo sapiens Interferon-induced protein with tetratricopeptide repeats 1 Proteins 0.000 claims description 17
• 102100027355 Interferon-induced protein with tetratricopeptide repeats 1 Human genes 0.000 claims description 17
• 230000008593 response to virus Effects 0.000 claims description 12
• 210000005259 peripheral blood Anatomy 0.000 claims description 10
• 239000011886 peripheral blood Substances 0.000 claims description 10
• 241000607479 Yersinia pestis Species 0.000 claims description 8
• 244000045947 parasite Species 0.000 claims description 8
• 244000052769 pathogen Species 0.000 claims description 8
• 229960000517 boceprevir Drugs 0.000 claims description 7
• LHHCSNFAOIFYRV-DOVBMPENSA-N boceprevir Chemical compound O=C([C@@H]1[C@@H]2[C@@H](C2(C)C)CN1C(=O)[C@@H](NC(=O)NC(C)(C)C)C(C)(C)C)NC(C(=O)C(N)=O)CC1CCC1 LHHCSNFAOIFYRV-DOVBMPENSA-N 0.000 claims description 7
• PJZPDFUUXKKDNB-KNINVFKUSA-N ciluprevir Chemical compound N([C@@H]1C(=O)N2[C@H](C(N[C@@]3(C[C@H]3\C=C/CCCCC1)C(O)=O)=O)C[C@H](C2)OC=1C2=CC=C(C=C2N=C(C=1)C=1N=C(NC(C)C)SC=1)OC)C(=O)OC1CCCC1 PJZPDFUUXKKDNB-KNINVFKUSA-N 0.000 claims description 7
• 229950006631 ciluprevir Drugs 0.000 claims description 7
• 230000004665 defense response Effects 0.000 claims description 6
• 230000024428 response to biotic stimulus Effects 0.000 claims description 6
• 230000021670 response to stimulus Effects 0.000 claims description 6
• 230000000694 effects Effects 0.000 description 315
• 102000004169 proteins and genes Human genes 0.000 description 152
• 235000018102 proteins Nutrition 0.000 description 145
• 238000013518 transcription Methods 0.000 description 140
• 230000035897 transcription Effects 0.000 description 137
• 230000031018 biological processes and functions Effects 0.000 description 96
• 230000004879 molecular function Effects 0.000 description 93
• 239000012528 membrane Substances 0.000 description 84
• 238000002560 therapeutic procedure Methods 0.000 description 79
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 74
• 108020004414 DNA Proteins 0.000 description 74
• 210000003850 cellular structure Anatomy 0.000 description 73
• 230000033228 biological regulation Effects 0.000 description 70
• 239000000523 sample Substances 0.000 description 70
• 102000039446 nucleic acids Human genes 0.000 description 50
• 108020004707 nucleic acids Proteins 0.000 description 50
• 150000007523 nucleic acids Chemical class 0.000 description 50
• 230000001976 improved effect Effects 0.000 description 46
• 102000005962 receptors Human genes 0.000 description 45
• 108020003175 receptors Proteins 0.000 description 45
• 210000004940 nucleus Anatomy 0.000 description 43
• 210000004027 cell Anatomy 0.000 description 42
• 230000027455 binding Effects 0.000 description 39
• 230000001419 dependent effect Effects 0.000 description 39
• 108091000080 Phosphotransferase Proteins 0.000 description 33
• 102000020233 phosphotransferase Human genes 0.000 description 33
• 230000032258 transport Effects 0.000 description 32
• 230000004060 metabolic process Effects 0.000 description 31
• 210000002381 plasma Anatomy 0.000 description 30
• 208000005176 Hepatitis C Diseases 0.000 description 29
• 230000006870 function Effects 0.000 description 27
• 230000011664 signaling Effects 0.000 description 27
• 238000011161 development Methods 0.000 description 26
• 230000018109 developmental process Effects 0.000 description 26
• 239000002773 nucleotide Substances 0.000 description 26
• 125000003729 nucleotide group Chemical group 0.000 description 26
• 239000003795 chemical substances by application Substances 0.000 description 25
• 102000004157 Hydrolases Human genes 0.000 description 24
• 108090000604 Hydrolases Proteins 0.000 description 24
• 102000004357 Transferases Human genes 0.000 description 24
• 108090000992 Transferases Proteins 0.000 description 24
• 210000000805 cytoplasm Anatomy 0.000 description 24
• 102000002004 Cytochrome P-450 Enzyme System Human genes 0.000 description 23
• 241000282414 Homo sapiens Species 0.000 description 23
• 101710198130 NADPH-cytochrome P450 reductase Proteins 0.000 description 23
• 230000036541 health Effects 0.000 description 23
• 102000003960 Ligases Human genes 0.000 description 21
• 108090000364 Ligases Proteins 0.000 description 21
• 241000700605 Viruses Species 0.000 description 21
• 230000003321 amplification Effects 0.000 description 21
• 230000015572 biosynthetic process Effects 0.000 description 21
• 238000003199 nucleic acid amplification method Methods 0.000 description 21
• 238000009396 hybridization Methods 0.000 description 20
• 229920001184 polypeptide Polymers 0.000 description 20
• 108090000765 processed proteins & peptides Proteins 0.000 description 20
• 102000004196 processed proteins & peptides Human genes 0.000 description 20
• 238000010361 transduction Methods 0.000 description 19
• 150000002500 ions Chemical class 0.000 description 18
• 230000026683 transduction Effects 0.000 description 18
• 102000035195 Peptidases Human genes 0.000 description 17
• 108091005804 Peptidases Proteins 0.000 description 17
• IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 description 17
• 239000000203 mixture Substances 0.000 description 17
• 239000012190 activator Substances 0.000 description 16
• 235000001014 amino acid Nutrition 0.000 description 16
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 15
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 15
• 229940047124 interferons Drugs 0.000 description 15
• 238000011269 treatment regimen Methods 0.000 description 15
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 14
• 239000003153 chemical reaction reagent Substances 0.000 description 14
• 230000001684 chronic effect Effects 0.000 description 14
• 150000001875 compounds Chemical class 0.000 description 14
• 229910021645 metal ion Inorganic materials 0.000 description 14
• 229960000329 ribavirin Drugs 0.000 description 14
• HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 description 14
• 229910052725 zinc Inorganic materials 0.000 description 14
• 239000011701 zinc Substances 0.000 description 14
• 101150036477 Gen gene Proteins 0.000 description 13
• 150000001413 amino acids Chemical class 0.000 description 13
• 230000006907 apoptotic process Effects 0.000 description 13
• 238000002648 combination therapy Methods 0.000 description 13
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 13
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
• 230000003834 intracellular effect Effects 0.000 description 12
• 102000013446 GTP Phosphohydrolases Human genes 0.000 description 11
• 102000006992 Interferon-alpha Human genes 0.000 description 11
• 108010047761 Interferon-alpha Proteins 0.000 description 11
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 11
• 208000037581 Persistent Infection Diseases 0.000 description 11
• 108090000848 Ubiquitin Proteins 0.000 description 11
• 102000044159 Ubiquitin Human genes 0.000 description 11
• 230000001413 cellular effect Effects 0.000 description 11
• 238000001514 detection method Methods 0.000 description 11
• 208000006454 hepatitis Diseases 0.000 description 11
• 108091006112 ATPases Proteins 0.000 description 10
• 102000057290 Adenosine Triphosphatases Human genes 0.000 description 10
• 108091006109 GTPases Proteins 0.000 description 10
• 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 10
• 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 10
• 239000004365 Protease Substances 0.000 description 10
• 230000009471 action Effects 0.000 description 10
• 239000003443 antiviral agent Substances 0.000 description 10
• 230000015556 catabolic process Effects 0.000 description 10
• 108020004999 messenger RNA Proteins 0.000 description 10
• 235000019419 proteases Nutrition 0.000 description 10
• 230000019491 signal transduction Effects 0.000 description 10
• 239000000427 antigen Substances 0.000 description 9
• 108091007433 antigens Proteins 0.000 description 9
• 102000036639 antigens Human genes 0.000 description 9
• 230000003197 catalytic effect Effects 0.000 description 9
• 230000000295 complement effect Effects 0.000 description 9
• RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Natural products OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 9
• 150000002632 lipids Chemical class 0.000 description 9
• 230000001404 mediated effect Effects 0.000 description 9
• 230000037425 regulation of transcription Effects 0.000 description 9
• 102000005593 Endopeptidases Human genes 0.000 description 8
• 108010059378 Endopeptidases Proteins 0.000 description 8
• 101000935043 Homo sapiens Integrin beta-1 Proteins 0.000 description 8
• 102100025304 Integrin beta-1 Human genes 0.000 description 8
• 108010047956 Nucleosomes Proteins 0.000 description 8
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical group [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 8
• PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 8
• FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 8
• 238000004458 analytical method Methods 0.000 description 8
• 210000004369 blood Anatomy 0.000 description 8
• 239000008280 blood Substances 0.000 description 8
• 239000002552 dosage form Substances 0.000 description 8
• 230000001965 increasing effect Effects 0.000 description 8
• 229910052751 metal Inorganic materials 0.000 description 8
• 239000002184 metal Substances 0.000 description 8
• 210000001623 nucleosome Anatomy 0.000 description 8
• 238000003752 polymerase chain reaction Methods 0.000 description 8
• 239000011591 potassium Substances 0.000 description 8
• 229910052700 potassium Inorganic materials 0.000 description 8
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 7
• 108091034117 Oligonucleotide Proteins 0.000 description 7
• 102000001253 Protein Kinase Human genes 0.000 description 7
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 7
• 230000004913 activation Effects 0.000 description 7
• 230000001154 acute effect Effects 0.000 description 7
• 210000003719 b-lymphocyte Anatomy 0.000 description 7
• 210000000349 chromosome Anatomy 0.000 description 7
• 239000012634 fragment Substances 0.000 description 7
• 231100000283 hepatitis Toxicity 0.000 description 7
• 208000019423 liver disease Diseases 0.000 description 7
• 210000003470 mitochondria Anatomy 0.000 description 7
• 238000010606 normalization Methods 0.000 description 7
• 230000026731 phosphorylation Effects 0.000 description 7
• 238000006366 phosphorylation reaction Methods 0.000 description 7
• 239000000902 placebo Substances 0.000 description 7
• 229940068196 placebo Drugs 0.000 description 7
• 235000019833 protease Nutrition 0.000 description 7
• 230000004952 protein activity Effects 0.000 description 7
• 108060006633 protein kinase Proteins 0.000 description 7
• 239000000758 substrate Substances 0.000 description 7
• 230000014616 translation Effects 0.000 description 7
• 101150028074 2 gene Proteins 0.000 description 6
• 101150090724 3 gene Proteins 0.000 description 6
• 101150033839 4 gene Proteins 0.000 description 6
• 101150096316 5 gene Proteins 0.000 description 6
• 101150039504 6 gene Proteins 0.000 description 6
• 101150101112 7 gene Proteins 0.000 description 6
• 101150044182 8 gene Proteins 0.000 description 6
• 230000004568 DNA-binding Effects 0.000 description 6
• 101710088194 Dehydrogenase Proteins 0.000 description 6
• 238000002965 ELISA Methods 0.000 description 6
• 108091006027 G proteins Proteins 0.000 description 6
• 102000030782 GTP binding Human genes 0.000 description 6
• 108091000058 GTP-Binding Proteins 0.000 description 6
• JBPUGFODGPKTDW-SFHVURJKSA-N [(3s)-oxolan-3-yl] n-[[3-[[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]carbamoylamino]phenyl]methyl]carbamate Chemical compound C=1C=C(C=2OC=NC=2)C(OC)=CC=1NC(=O)NC(C=1)=CC=CC=1CNC(=O)O[C@H]1CCOC1 JBPUGFODGPKTDW-SFHVURJKSA-N 0.000 description 6
• 239000002253 acid Substances 0.000 description 6
• 238000003491 array Methods 0.000 description 6
• 230000036765 blood level Effects 0.000 description 6
• HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
• 210000004292 cytoskeleton Anatomy 0.000 description 6
• 230000005860 defense response to virus Effects 0.000 description 6
• 230000004069 differentiation Effects 0.000 description 6
• 201000010099 disease Diseases 0.000 description 6
• 208000035475 disorder Diseases 0.000 description 6
• 239000007850 fluorescent dye Substances 0.000 description 6
• OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 6
• 210000003494 hepatocyte Anatomy 0.000 description 6
• 210000000653 nervous system Anatomy 0.000 description 6
• 238000012163 sequencing technique Methods 0.000 description 6
• 238000009097 single-agent therapy Methods 0.000 description 6
• 208000024891 symptom Diseases 0.000 description 6
• 238000012360 testing method Methods 0.000 description 6
• 230000003827 upregulation Effects 0.000 description 6
• 102100031172 C-C chemokine receptor type 1 Human genes 0.000 description 5
• 101710149814 C-C chemokine receptor type 1 Proteins 0.000 description 5
• 102100034808 CCAAT/enhancer-binding protein alpha Human genes 0.000 description 5
• 102100035619 DNA-(apurinic or apyrimidinic site) lyase Human genes 0.000 description 5
• 241000255582 Drosophilidae Species 0.000 description 5
• 101150090421 GO gene Proteins 0.000 description 5
• 108010024636 Glutathione Proteins 0.000 description 5
• 108010033040 Histones Proteins 0.000 description 5
• 101000945515 Homo sapiens CCAAT/enhancer-binding protein alpha Proteins 0.000 description 5
• 101001137256 Homo sapiens DNA-(apurinic or apyrimidinic site) lyase Proteins 0.000 description 5
• 101001032342 Homo sapiens Interferon regulatory factor 7 Proteins 0.000 description 5
• 102100038070 Interferon regulatory factor 7 Human genes 0.000 description 5
• 108010044467 Isoenzymes Proteins 0.000 description 5
• 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 5
• 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 5
• 108091023040 Transcription factor Proteins 0.000 description 5
• 102000040945 Transcription factor Human genes 0.000 description 5
• 230000022131 cell cycle Effects 0.000 description 5
• 230000004663 cell proliferation Effects 0.000 description 5
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 5
• 235000018417 cysteine Nutrition 0.000 description 5
• 230000007423 decrease Effects 0.000 description 5
• 230000030609 dephosphorylation Effects 0.000 description 5
• 230000008030 elimination Effects 0.000 description 5
• 238000003379 elimination reaction Methods 0.000 description 5
• 229960003180 glutathione Drugs 0.000 description 5
• 238000010348 incorporation Methods 0.000 description 5
• 229960000367 inositol Drugs 0.000 description 5
• 210000004185 liver Anatomy 0.000 description 5
• 102000006240 membrane receptors Human genes 0.000 description 5
• 239000002245 particle Substances 0.000 description 5
• 230000001105 regulatory effect Effects 0.000 description 5
• 230000003938 response to stress Effects 0.000 description 5
• 210000003660 reticulum Anatomy 0.000 description 5
• 239000011734 sodium Substances 0.000 description 5
• 239000000126 substance Substances 0.000 description 5
• 238000013519 translation Methods 0.000 description 5
• 230000034512 ubiquitination Effects 0.000 description 5
• FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 4
• KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 4
• 102000019034 Chemokines Human genes 0.000 description 4
• 108010012236 Chemokines Proteins 0.000 description 4
• 208000006154 Chronic hepatitis C Diseases 0.000 description 4
• 208000003311 Cytochrome P-450 Enzyme Inhibitors Diseases 0.000 description 4
• 102000004190 Enzymes Human genes 0.000 description 4
• 108090000790 Enzymes Proteins 0.000 description 4
• 206010019799 Hepatitis viral Diseases 0.000 description 4
• 108010078049 Interferon alpha-2 Proteins 0.000 description 4
• XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
• 102000004195 Isomerases Human genes 0.000 description 4
• 108090000769 Isomerases Proteins 0.000 description 4
• 108060004795 Methyltransferase Proteins 0.000 description 4
• RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 4
• 102000004245 Proteasome Endopeptidase Complex Human genes 0.000 description 4
• 108090000708 Proteasome Endopeptidase Complex Proteins 0.000 description 4
• 230000004570 RNA-binding Effects 0.000 description 4
• 102000004389 Ribonucleoproteins Human genes 0.000 description 4
• 108010081734 Ribonucleoproteins Proteins 0.000 description 4
• 210000001744 T-lymphocyte Anatomy 0.000 description 4
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 4
• 239000004473 Threonine Substances 0.000 description 4
• GYCPCOJTCINIFZ-JXFKEZNVSA-N [(2s)-1-cyanobutan-2-yl] n-[(1s)-1-[3-[[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]carbamoylamino]phenyl]ethyl]carbamate Chemical compound N#CC[C@H](CC)OC(=O)N[C@@H](C)C1=CC=CC(NC(=O)NC=2C=C(OC)C(C=3OC=NC=3)=CC=2)=C1 GYCPCOJTCINIFZ-JXFKEZNVSA-N 0.000 description 4
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
• ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 4
• OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 4
• 230000000845 anti-microbial effect Effects 0.000 description 4
• 238000003556 assay Methods 0.000 description 4
• 230000021164 cell adhesion Effects 0.000 description 4
• 230000035605 chemotaxis Effects 0.000 description 4
• 230000003081 coactivator Effects 0.000 description 4
• 230000000875 corresponding effect Effects 0.000 description 4
• 230000007123 defense Effects 0.000 description 4
• 238000006209 dephosphorylation reaction Methods 0.000 description 4
• 230000003828 downregulation Effects 0.000 description 4
• 229940088598 enzyme Drugs 0.000 description 4
• 235000019152 folic acid Nutrition 0.000 description 4
• 239000011724 folic acid Substances 0.000 description 4
• 238000009472 formulation Methods 0.000 description 4
• UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 4
• 230000002519 immonomodulatory effect Effects 0.000 description 4
• 230000006872 improvement Effects 0.000 description 4
• 230000006698 induction Effects 0.000 description 4
• 230000001939 inductive effect Effects 0.000 description 4
• 230000002757 inflammatory effect Effects 0.000 description 4
• 102000006495 integrins Human genes 0.000 description 4
• 108010044426 integrins Proteins 0.000 description 4
• 230000003993 interaction Effects 0.000 description 4
• 238000012544 monitoring process Methods 0.000 description 4
• 230000037361 pathway Effects 0.000 description 4
• 108010092853 peginterferon alfa-2a Proteins 0.000 description 4
• 239000008194 pharmaceutical composition Substances 0.000 description 4
• 230000009467 reduction Effects 0.000 description 4
• 230000002829 reductive effect Effects 0.000 description 4
• 230000008439 repair process Effects 0.000 description 4
• 229960003471 retinol Drugs 0.000 description 4
• 235000020944 retinol Nutrition 0.000 description 4
• 239000011607 retinol Substances 0.000 description 4
• 239000007962 solid dispersion Substances 0.000 description 4
• 238000010798 ubiquitination Methods 0.000 description 4
• 101710169336 5'-deoxyadenosine deaminase Proteins 0.000 description 3
• 102000055025 Adenosine deaminases Human genes 0.000 description 3
• 108700028369 Alleles Proteins 0.000 description 3
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
• 102000016736 Cyclin Human genes 0.000 description 3
• 108050006400 Cyclin Proteins 0.000 description 3
• 102000004127 Cytokines Human genes 0.000 description 3
• 108090000695 Cytokines Proteins 0.000 description 3
• 206010016654 Fibrosis Diseases 0.000 description 3
• 241000134307 Hepatitis C virus genotype 1 Species 0.000 description 3
• 241000122128 Hepatitis C virus genotype 2 Species 0.000 description 3
• 241001093325 Hepatitis C virus genotype 3 Species 0.000 description 3
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical group C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
• 108060003951 Immunoglobulin Proteins 0.000 description 3
• 102100040018 Interferon alpha-2 Human genes 0.000 description 3
• 108090000862 Ion Channels Proteins 0.000 description 3
• 102000004310 Ion Channels Human genes 0.000 description 3
• FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
• 108091022875 Microtubule Proteins 0.000 description 3
• 102000029749 Microtubule Human genes 0.000 description 3
• 108010070047 Notch Receptors Proteins 0.000 description 3
• 102000005650 Notch Receptors Human genes 0.000 description 3
• 108700020796 Oncogene Proteins 0.000 description 3
• 102000004316 Oxidoreductases Human genes 0.000 description 3
• 108090000854 Oxidoreductases Proteins 0.000 description 3
• 229920000388 Polyphosphate Polymers 0.000 description 3
• NCDNCNXCDXHOMX-UHFFFAOYSA-N Ritonavir Natural products C=1C=CC=CC=1CC(NC(=O)OCC=1SC=NC=1)C(O)CC(CC=1C=CC=CC=1)NC(=O)C(C(C)C)NC(=O)N(C)CC1=CSC(C(C)C)=N1 NCDNCNXCDXHOMX-UHFFFAOYSA-N 0.000 description 3
• 101710120037 Toxin CcdB Proteins 0.000 description 3
• 239000004480 active ingredient Substances 0.000 description 3
• 238000013475 authorization Methods 0.000 description 3
• 230000008901 benefit Effects 0.000 description 3
• 230000037396 body weight Effects 0.000 description 3
• 239000011575 calcium Substances 0.000 description 3
• 229910052791 calcium Inorganic materials 0.000 description 3
• 229910001424 calcium ion Inorganic materials 0.000 description 3
• 230000010261 cell growth Effects 0.000 description 3
• 210000000170 cell membrane Anatomy 0.000 description 3
• 230000008859 change Effects 0.000 description 3
• 235000012000 cholesterol Nutrition 0.000 description 3
• 230000007882 cirrhosis Effects 0.000 description 3
• 208000019425 cirrhosis of liver Diseases 0.000 description 3
• 239000005515 coenzyme Substances 0.000 description 3
• 239000002299 complementary DNA Substances 0.000 description 3
• 238000012790 confirmation Methods 0.000 description 3
• 230000002596 correlated effect Effects 0.000 description 3
• 125000004122 cyclic group Chemical group 0.000 description 3
• 235000014113 dietary fatty acids Nutrition 0.000 description 3
• 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 3
• 239000006185 dispersion Substances 0.000 description 3
• 238000010494 dissociation reaction Methods 0.000 description 3
• 230000005593 dissociations Effects 0.000 description 3
• 230000012202 endocytosis Effects 0.000 description 3
• 229930195729 fatty acid Natural products 0.000 description 3
• 239000000194 fatty acid Substances 0.000 description 3
• 102000018146 globin Human genes 0.000 description 3
• 108060003196 globin Proteins 0.000 description 3
• 208000002672 hepatitis B Diseases 0.000 description 3
• 206010073071 hepatocellular carcinoma Diseases 0.000 description 3
• 231100000844 hepatocellular carcinoma Toxicity 0.000 description 3
• 230000013632 homeostatic process Effects 0.000 description 3
• 239000001257 hydrogen Substances 0.000 description 3
• 229910052739 hydrogen Inorganic materials 0.000 description 3
• 125000004435 hydrogen atom Chemical class [H]* 0.000 description 3
• 230000036039 immunity Effects 0.000 description 3
• 102000018358 immunoglobulin Human genes 0.000 description 3
• 230000028709 inflammatory response Effects 0.000 description 3
• 108700027921 interferon tau Proteins 0.000 description 3
• 230000003902 lesion Effects 0.000 description 3
• 239000003446 ligand Substances 0.000 description 3
• 201000007270 liver cancer Diseases 0.000 description 3
• 208000014018 liver neoplasm Diseases 0.000 description 3
• 230000033001 locomotion Effects 0.000 description 3
• 210000004698 lymphocyte Anatomy 0.000 description 3
• 239000011777 magnesium Substances 0.000 description 3
• 229910052749 magnesium Inorganic materials 0.000 description 3
• 108020004084 membrane receptors Proteins 0.000 description 3
• 238000002493 microarray Methods 0.000 description 3
• 210000001589 microsome Anatomy 0.000 description 3
• 230000002438 mitochondrial effect Effects 0.000 description 3
• 230000004048 modification Effects 0.000 description 3
• 238000012986 modification Methods 0.000 description 3
• 230000035772 mutation Effects 0.000 description 3
• 239000002777 nucleoside Substances 0.000 description 3
• 150000003833 nucleoside derivatives Chemical class 0.000 description 3
• 229940002988 pegasys Drugs 0.000 description 3
• 210000004976 peripheral blood cell Anatomy 0.000 description 3
• 150000003904 phospholipids Chemical class 0.000 description 3
• 239000001205 polyphosphate Substances 0.000 description 3
• 235000011176 polyphosphates Nutrition 0.000 description 3
• 230000003389 potentiating effect Effects 0.000 description 3
• 239000002243 precursor Substances 0.000 description 3
• 238000012545 processing Methods 0.000 description 3
• 230000009145 protein modification Effects 0.000 description 3
• 230000017854 proteolysis Effects 0.000 description 3
• 229960000311 ritonavir Drugs 0.000 description 3
• NCDNCNXCDXHOMX-XGKFQTDJSA-N ritonavir Chemical compound N([C@@H](C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1SC=NC=1)CC=1C=CC=CC=1)C(=O)N(C)CC1=CSC(C(C)C)=N1 NCDNCNXCDXHOMX-XGKFQTDJSA-N 0.000 description 3
• 238000012216 screening Methods 0.000 description 3
• 229910052708 sodium Inorganic materials 0.000 description 3
• 239000007787 solid Substances 0.000 description 3
• 208000011580 syndromic disease Diseases 0.000 description 3
• 238000003786 synthesis reaction Methods 0.000 description 3
• 230000005758 transcription activity Effects 0.000 description 3
• 108020005087 unfolded proteins Proteins 0.000 description 3
• 201000001862 viral hepatitis Diseases 0.000 description 3
• 230000009385 viral infection Effects 0.000 description 3
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
• XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 2
• ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 description 2
• 102000051017 ATP-dependent activity proteins Human genes 0.000 description 2
• 108700012538 ATP-dependent activity proteins Proteins 0.000 description 2
• 108010088751 Albumins Proteins 0.000 description 2
• 102000009027 Albumins Human genes 0.000 description 2
• 208000022309 Alcoholic Liver disease Diseases 0.000 description 2
• CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
• 239000002126 C01EB10 - Adenosine Substances 0.000 description 2
• 102000000584 Calmodulin Human genes 0.000 description 2
• 108010041952 Calmodulin Proteins 0.000 description 2
• 108010078791 Carrier Proteins Proteins 0.000 description 2
• 108010001857 Cell Surface Receptors Proteins 0.000 description 2
• 108091006146 Channels Proteins 0.000 description 2
• PCLITLDOTJTVDJ-UHFFFAOYSA-N Chlormethiazole Chemical compound CC=1N=CSC=1CCCl PCLITLDOTJTVDJ-UHFFFAOYSA-N 0.000 description 2
• 108010077544 Chromatin Proteins 0.000 description 2
• 206010008909 Chronic Hepatitis Diseases 0.000 description 2
• PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 2
• 229930105110 Cyclosporin A Natural products 0.000 description 2
• 108010036949 Cyclosporine Proteins 0.000 description 2
• 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
• 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
• BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 2
• MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
• 102100031780 Endonuclease Human genes 0.000 description 2
• 108010042407 Endonucleases Proteins 0.000 description 2
• ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
• 241000206602 Eukaryota Species 0.000 description 2
• 229930091371 Fructose Natural products 0.000 description 2
• 239000005715 Fructose Substances 0.000 description 2
• 102100021736 Galectin-1 Human genes 0.000 description 2
• 102100034294 Glutathione synthetase Human genes 0.000 description 2
• SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 2
• 101001011382 Homo sapiens Interferon regulatory factor 3 Proteins 0.000 description 2
• 101000595548 Homo sapiens TIR domain-containing adapter molecule 1 Proteins 0.000 description 2
• 206010021143 Hypoxia Diseases 0.000 description 2
• 102000043138 IRF family Human genes 0.000 description 2
• 108091054729 IRF family Proteins 0.000 description 2
• 102100029199 Iduronate 2-sulfatase Human genes 0.000 description 2
• 101710200424 Inosine-5'-monophosphate dehydrogenase Proteins 0.000 description 2
• 102100029843 Interferon regulatory factor 3 Human genes 0.000 description 2
• 108010074328 Interferon-gamma Proteins 0.000 description 2
• 102000000588 Interleukin-2 Human genes 0.000 description 2
• 108010002350 Interleukin-2 Proteins 0.000 description 2
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
• 206010025323 Lymphomas Diseases 0.000 description 2
• 102100024295 Maltase-glucoamylase Human genes 0.000 description 2
• 102000018697 Membrane Proteins Human genes 0.000 description 2
• 108010052285 Membrane Proteins Proteins 0.000 description 2
• 102000003939 Membrane transport proteins Human genes 0.000 description 2
• 108090000301 Membrane transport proteins Proteins 0.000 description 2
• 102100023727 Mitochondrial antiviral-signaling protein Human genes 0.000 description 2
• 101710142315 Mitochondrial antiviral-signaling protein Proteins 0.000 description 2
• OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
• 238000000636 Northern blotting Methods 0.000 description 2
• 108020003217 Nuclear RNA Proteins 0.000 description 2
• 102000043141 Nuclear RNA Human genes 0.000 description 2
• 102100034574 P protein Human genes 0.000 description 2
• 101710181008 P protein Proteins 0.000 description 2
• 229910019142 PO4 Inorganic materials 0.000 description 2
• 108010064785 Phospholipases Proteins 0.000 description 2
• 102000015439 Phospholipases Human genes 0.000 description 2
• 101710177166 Phosphoprotein Proteins 0.000 description 2
• 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 2
• 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 2
• 102000004879 Racemases and epimerases Human genes 0.000 description 2
• 108090001066 Racemases and epimerases Proteins 0.000 description 2
• 108091027981 Response element Proteins 0.000 description 2
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
• 206010039491 Sarcoma Diseases 0.000 description 2
• 108010090804 Streptavidin Proteins 0.000 description 2
• 102100036073 TIR domain-containing adapter molecule 1 Human genes 0.000 description 2
• 102000003929 Transaminases Human genes 0.000 description 2
• 108090000340 Transaminases Proteins 0.000 description 2
• SHGAZHPCJJPHSC-NWVFGJFESA-N Tretinoin Chemical compound OC(=O)/C=C(\C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NWVFGJFESA-N 0.000 description 2
• 241000251539 Vertebrata <Metazoa> Species 0.000 description 2
• 208000036142 Viral infection Diseases 0.000 description 2
• 206010052428 Wound Diseases 0.000 description 2
• 208000027418 Wounds and injury Diseases 0.000 description 2
• 229960005305 adenosine Drugs 0.000 description 2
• 108010028144 alpha-Glucosidases Proteins 0.000 description 2
• 239000003098 androgen Substances 0.000 description 2
• 230000008436 biogenesis Effects 0.000 description 2
• 150000001720 carbohydrates Chemical class 0.000 description 2
• 235000014633 carbohydrates Nutrition 0.000 description 2
• 230000023549 cell-cell signaling Effects 0.000 description 2
• 238000006243 chemical reaction Methods 0.000 description 2
• 210000003483 chromatin Anatomy 0.000 description 2
• 230000011855 chromosome organization Effects 0.000 description 2
• 229960001265 ciclosporin Drugs 0.000 description 2
• 229960004414 clomethiazole Drugs 0.000 description 2
• 230000015271 coagulation Effects 0.000 description 2
• 238000005345 coagulation Methods 0.000 description 2
• 239000000470 constituent Substances 0.000 description 2
• 229940055354 copegus Drugs 0.000 description 2
• 239000013078 crystal Substances 0.000 description 2
• 229930182912 cyclosporin Natural products 0.000 description 2
• 210000000172 cytosol Anatomy 0.000 description 2
• 238000006731 degradation reaction Methods 0.000 description 2
• WHBIGIKBNXZKFE-UHFFFAOYSA-N delavirdine Chemical compound CC(C)NC1=CC=CN=C1N1CCN(C(=O)C=2NC3=CC=C(NS(C)(=O)=O)C=C3C=2)CC1 WHBIGIKBNXZKFE-UHFFFAOYSA-N 0.000 description 2
• 210000004443 dendritic cell Anatomy 0.000 description 2
• 238000003745 diagnosis Methods 0.000 description 2
• 238000002405 diagnostic procedure Methods 0.000 description 2
• 230000029087 digestion Effects 0.000 description 2
• 238000006471 dimerization reaction Methods 0.000 description 2
• 229910001882 dioxygen Inorganic materials 0.000 description 2
• 238000006073 displacement reaction Methods 0.000 description 2
• 238000005516 engineering process Methods 0.000 description 2
• 230000002255 enzymatic effect Effects 0.000 description 2
• 230000029142 excretion Effects 0.000 description 2
• 229940014144 folate Drugs 0.000 description 2
• 229960000304 folic acid Drugs 0.000 description 2
• RIKMMFOAQPJVMX-UHFFFAOYSA-N fomepizole Chemical compound CC=1C=NNC=1 RIKMMFOAQPJVMX-UHFFFAOYSA-N 0.000 description 2
• 229960004285 fomepizole Drugs 0.000 description 2
• 229930195712 glutamate Natural products 0.000 description 2
• 238000005734 heterodimerization reaction Methods 0.000 description 2
• 230000005745 host immune response Effects 0.000 description 2
• 230000007954 hypoxia Effects 0.000 description 2
• 229960002751 imiquimod Drugs 0.000 description 2
• DOUYETYNHWVLEO-UHFFFAOYSA-N imiquimod Chemical compound C1=CC=CC2=C3N(CC(C)C)C=NC3=C(N)N=C21 DOUYETYNHWVLEO-UHFFFAOYSA-N 0.000 description 2
• 230000002779 inactivation Effects 0.000 description 2
• 230000002401 inhibitory effect Effects 0.000 description 2
• 230000005764 inhibitory process Effects 0.000 description 2
• CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
• 229960003507 interferon alfa-2b Drugs 0.000 description 2
• 108010006088 interferon alfa-n1 Proteins 0.000 description 2
• 230000037427 ion transport Effects 0.000 description 2
• 229910052742 iron Inorganic materials 0.000 description 2
• 229960004125 ketoconazole Drugs 0.000 description 2
• 210000000265 leukocyte Anatomy 0.000 description 2
• 210000003712 lysosome Anatomy 0.000 description 2
• 230000001868 lysosomic effect Effects 0.000 description 2
• 238000004519 manufacturing process Methods 0.000 description 2
• 239000011159 matrix material Substances 0.000 description 2
• 230000007246 mechanism Effects 0.000 description 2
• 210000004688 microtubule Anatomy 0.000 description 2
• 230000005012 migration Effects 0.000 description 2
• 238000013508 migration Methods 0.000 description 2
• 239000003226 mitogen Substances 0.000 description 2
• 230000011278 mitosis Effects 0.000 description 2
• 210000001616 monocyte Anatomy 0.000 description 2
• 230000017095 negative regulation of cell growth Effects 0.000 description 2
• 238000003499 nucleic acid array Methods 0.000 description 2
• 238000007254 oxidation reaction Methods 0.000 description 2
• 108010092851 peginterferon alfa-2b Proteins 0.000 description 2
• 230000008447 perception Effects 0.000 description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
• 239000010452 phosphate Substances 0.000 description 2
• 101150109000 pik3ip1 gene Proteins 0.000 description 2
• 102000054765 polymorphisms of proteins Human genes 0.000 description 2
• 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
• 229910001414 potassium ion Inorganic materials 0.000 description 2
• 238000002360 preparation method Methods 0.000 description 2
• 230000002265 prevention Effects 0.000 description 2
• 239000000047 product Substances 0.000 description 2
• 239000000186 progesterone Substances 0.000 description 2
• 229960003387 progesterone Drugs 0.000 description 2
• 238000003498 protein array Methods 0.000 description 2
• 230000009822 protein phosphorylation Effects 0.000 description 2
• 238000003127 radioimmunoassay Methods 0.000 description 2
• 229930002330 retinoic acid Natural products 0.000 description 2
• 230000002441 reversible effect Effects 0.000 description 2
• 238000012552 review Methods 0.000 description 2
• 238000005096 rolling process Methods 0.000 description 2
• 210000004761 scalp Anatomy 0.000 description 2
• CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
• 230000028327 secretion Effects 0.000 description 2
• 150000003354 serine derivatives Chemical class 0.000 description 2
• 230000035939 shock Effects 0.000 description 2
• 102000034285 signal transducing proteins Human genes 0.000 description 2
• 108091006024 signal transducing proteins Proteins 0.000 description 2
• 229910001415 sodium ion Inorganic materials 0.000 description 2
• MIXCUJKCXRNYFM-UHFFFAOYSA-M sodium;diiodomethanesulfonate;n-propyl-n-[2-(2,4,6-trichlorophenoxy)ethyl]imidazole-1-carboxamide Chemical compound [Na+].[O-]S(=O)(=O)C(I)I.C1=CN=CN1C(=O)N(CCC)CCOC1=C(Cl)C=C(Cl)C=C1Cl MIXCUJKCXRNYFM-UHFFFAOYSA-M 0.000 description 2
• 241000894007 species Species 0.000 description 2
• 238000010922 spray-dried dispersion Methods 0.000 description 2
• 238000000528 statistical test Methods 0.000 description 2
• 230000000638 stimulation Effects 0.000 description 2
• 239000013589 supplement Substances 0.000 description 2
• 230000001225 therapeutic effect Effects 0.000 description 2
• 238000004448 titration Methods 0.000 description 2
• 238000012546 transfer Methods 0.000 description 2
• 229960001727 tretinoin Drugs 0.000 description 2
• 229960005041 troleandomycin Drugs 0.000 description 2
• LQCLVBQBTUVCEQ-QTFUVMRISA-N troleandomycin Chemical compound O1[C@@H](C)[C@H](OC(C)=O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](C)C(=O)O[C@H](C)[C@H](C)[C@H](OC(C)=O)[C@@H](C)C(=O)[C@@]2(OC2)C[C@H](C)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)OC(C)=O)[C@H]1C LQCLVBQBTUVCEQ-QTFUVMRISA-N 0.000 description 2
• 241000712461 unidentified influenza virus Species 0.000 description 2
• 238000011144 upstream manufacturing Methods 0.000 description 2
• 229960005486 vaccine Drugs 0.000 description 2
• 210000003934 vacuole Anatomy 0.000 description 2
• 230000029812 viral genome replication Effects 0.000 description 2
• 238000001262 western blot Methods 0.000 description 2
• GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 1
• RTHCYVBBDHJXIQ-MRXNPFEDSA-N (R)-fluoxetine Chemical compound O([C@H](CCNC)C=1C=CC=CC=1)C1=CC=C(C(F)(F)F)C=C1 RTHCYVBBDHJXIQ-MRXNPFEDSA-N 0.000 description 1
• 230000006269 (delayed) early viral mRNA transcription Effects 0.000 description 1
• ZEWJFUNFEABPGL-UHFFFAOYSA-N 1,2,4-triazole-3-carboxamide Chemical compound NC(=O)C=1N=CNN=1 ZEWJFUNFEABPGL-UHFFFAOYSA-N 0.000 description 1
• KVUXYQHEESDGIJ-UHFFFAOYSA-N 10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthrene-3,16-diol Chemical compound C1CC2CC(O)CCC2(C)C2C1C1CC(O)CC1(C)CC2 KVUXYQHEESDGIJ-UHFFFAOYSA-N 0.000 description 1
• NCYCYZXNIZJOKI-IOUUIBBYSA-N 11-cis-retinal Chemical compound O=C/C=C(\C)/C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-IOUUIBBYSA-N 0.000 description 1
• VHVPQPYKVGDNFY-DFMJLFEVSA-N 2-[(2r)-butan-2-yl]-4-[4-[4-[4-[[(2r,4s)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one Chemical compound O=C1N([C@H](C)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(OC3)C=3C(=CC(Cl)=CC=3)Cl)=CC=2)C=C1 VHVPQPYKVGDNFY-DFMJLFEVSA-N 0.000 description 1
• KPGXRSRHYNQIFN-UHFFFAOYSA-L 2-oxoglutarate(2-) Chemical group [O-]C(=O)CCC(=O)C([O-])=O KPGXRSRHYNQIFN-UHFFFAOYSA-L 0.000 description 1
• 101710099475 3'-phosphoadenosine 5'-phosphate phosphatase Proteins 0.000 description 1
• PWJFNRJRHXWEPT-UHFFFAOYSA-N ADP ribose Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OCC(O)C(O)C(O)C=O)C(O)C1O PWJFNRJRHXWEPT-UHFFFAOYSA-N 0.000 description 1
• SRNWOUGRCWSEMX-KEOHHSTQSA-N ADP-beta-D-ribose Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H]1O)O)N1C=2N=CN=C(C=2N=C1)N)OP(O)(=O)OP(O)(=O)OC[C@H]1O[C@@H](O)[C@H](O)[C@@H]1O SRNWOUGRCWSEMX-KEOHHSTQSA-N 0.000 description 1
• 208000004998 Abdominal Pain Diseases 0.000 description 1
• DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 1
• 108010051457 Acid Phosphatase Proteins 0.000 description 1
• 102000013563 Acid Phosphatase Human genes 0.000 description 1
• 206010048998 Acute phase reaction Diseases 0.000 description 1
• 102000057234 Acyl transferases Human genes 0.000 description 1
• 108700016155 Acyl transferases Proteins 0.000 description 1
• 208000010507 Adenocarcinoma of Lung Diseases 0.000 description 1
• 102100036664 Adenosine deaminase Human genes 0.000 description 1
• 101710150365 Albumin-1 Proteins 0.000 description 1
• 229920000310 Alpha glucan Polymers 0.000 description 1
• 102000009091 Amyloidogenic Proteins Human genes 0.000 description 1
• 108010048112 Amyloidogenic Proteins Proteins 0.000 description 1
• 102100037435 Antiviral innate immune response receptor RIG-I Human genes 0.000 description 1
• 101710127675 Antiviral innate immune response receptor RIG-I Proteins 0.000 description 1
• 101150045895 Apela gene Proteins 0.000 description 1
• 101100049539 Arabidopsis thaliana VPS9A gene Proteins 0.000 description 1
• 206010003694 Atrophy Diseases 0.000 description 1
• 241000894006 Bacteria Species 0.000 description 1
• 101710129995 Basic leucine zipper 2 Proteins 0.000 description 1
• KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 1
• 241001598984 Bromius obscurus Species 0.000 description 1
• 241000197194 Bulla Species 0.000 description 1
• 102000004555 Butyrophilins Human genes 0.000 description 1
• 108010017533 Butyrophilins Proteins 0.000 description 1
• 101710117545 C protein Proteins 0.000 description 1
• 102100025248 C-X-C motif chemokine 10 Human genes 0.000 description 1
• YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
• 108010041397 CD4 Antigens Proteins 0.000 description 1
• 101150026353 CD46 gene Proteins 0.000 description 1
• QAGYKUNXZHXKMR-UHFFFAOYSA-N CPD000469186 Natural products CC1=C(O)C=CC=C1C(=O)NC(C(O)CN1C(CC2CCCCC2C1)C(=O)NC(C)(C)C)CSC1=CC=CC=C1 QAGYKUNXZHXKMR-UHFFFAOYSA-N 0.000 description 1
• 101100494319 Caenorhabditis elegans bub-3 gene Proteins 0.000 description 1
• 101100008044 Caenorhabditis elegans cut-1 gene Proteins 0.000 description 1
• BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
• 239000004132 Calcium polyphosphate Substances 0.000 description 1
• 101710132601 Capsid protein Proteins 0.000 description 1
• 239000004215 Carbon black (E152) Substances 0.000 description 1
• 108010076667 Caspases Proteins 0.000 description 1
• 102000011727 Caspases Human genes 0.000 description 1
• 102000011068 Cdc42 Human genes 0.000 description 1
• 102000009410 Chemokine receptor Human genes 0.000 description 1
• 108050000299 Chemokine receptor Proteins 0.000 description 1
• 241000207199 Citrus Species 0.000 description 1
• ZTDFZLVUIVPZDU-QGNHJMHWSA-N Cnicin Chemical compound OC[C@H](O)C(=C)C(=O)O[C@H]1CC(/C)=C/CC\C(CO)=C\[C@H]2OC(=O)C(=C)[C@@H]21 ZTDFZLVUIVPZDU-QGNHJMHWSA-N 0.000 description 1
• RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical class O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 1
• 108091026890 Coding region Proteins 0.000 description 1
• RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
• 102000003903 Cyclin-dependent kinases Human genes 0.000 description 1
• 108090000266 Cyclin-dependent kinases Proteins 0.000 description 1
• 229940122280 Cytochrome P450 inhibitor Drugs 0.000 description 1
• 102100031655 Cytochrome b5 Human genes 0.000 description 1
• 102000018832 Cytochromes Human genes 0.000 description 1
• 108010052832 Cytochromes Proteins 0.000 description 1
• 108010007167 Cytochromes b5 Proteins 0.000 description 1
• DEFJQIDDEAULHB-QWWZWVQMSA-N D-alanyl-D-alanine Chemical compound C[C@@H]([NH3+])C(=O)N[C@H](C)C([O-])=O DEFJQIDDEAULHB-QWWZWVQMSA-N 0.000 description 1
• 108020001738 DNA Glycosylase Proteins 0.000 description 1
• 230000005778 DNA damage Effects 0.000 description 1
• 231100000277 DNA damage Toxicity 0.000 description 1
• 102000028381 DNA glycosylase Human genes 0.000 description 1
• 102000001477 Deubiquitinating Enzymes Human genes 0.000 description 1
• 108010093668 Deubiquitinating Enzymes Proteins 0.000 description 1
• 238000009007 Diagnostic Kit Methods 0.000 description 1
• 102100029791 Double-stranded RNA-specific adenosine deaminase Human genes 0.000 description 1
• 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
• 102100021238 Dynamin-2 Human genes 0.000 description 1
• 102100030013 Endoribonuclease Human genes 0.000 description 1
• 101710199605 Endoribonuclease Proteins 0.000 description 1
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
• 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
• 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
• 108010008177 Fd immunoglobulins Proteins 0.000 description 1
• 108010067306 Fibronectins Proteins 0.000 description 1
• 102000016359 Fibronectins Human genes 0.000 description 1
• 241000710781 Flaviviridae Species 0.000 description 1
• RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
• YXWOAJXNVLXPMU-ZXXMMSQZSA-N Fructose 2,6-diphosphate Chemical compound OP(=O)(O)O[C@]1(CO)O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O YXWOAJXNVLXPMU-ZXXMMSQZSA-N 0.000 description 1
• 102100022633 Fructose-2,6-bisphosphatase Human genes 0.000 description 1
• 102000018898 GTPase-Activating Proteins Human genes 0.000 description 1
• 108010027920 GTPase-Activating Proteins Proteins 0.000 description 1
• 206010071602 Genetic polymorphism Diseases 0.000 description 1
• 108010036164 Glutathione synthase Proteins 0.000 description 1
• 229920002683 Glycosaminoglycan Polymers 0.000 description 1
• 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
• 108010051696 Growth Hormone Proteins 0.000 description 1
• 102000015779 HDL Lipoproteins Human genes 0.000 description 1
• 108010010234 HDL Lipoproteins Proteins 0.000 description 1
• 101150026303 HEX1 gene Proteins 0.000 description 1
• 102000004447 HSP40 Heat-Shock Proteins Human genes 0.000 description 1
• 108010042283 HSP40 Heat-Shock Proteins Proteins 0.000 description 1
• 229920002971 Heparan sulfate Polymers 0.000 description 1
• 102100031415 Hepatic triacylglycerol lipase Human genes 0.000 description 1
• 241000700721 Hepatitis B virus Species 0.000 description 1
• 241000282412 Homo Species 0.000 description 1
• 101000865408 Homo sapiens Double-stranded RNA-specific adenosine deaminase Proteins 0.000 description 1
• 101000817607 Homo sapiens Dynamin-2 Proteins 0.000 description 1
• 101000959794 Homo sapiens Interferon alpha-2 Proteins 0.000 description 1
• 101000959664 Homo sapiens Interferon-induced protein 44-like Proteins 0.000 description 1
• 101000819111 Homo sapiens Trans-acting T-cell-specific transcription factor GATA-3 Proteins 0.000 description 1
• 101000829171 Hypocrea virens (strain Gv29-8 / FGSC 10586) Effector TSP1 Proteins 0.000 description 1
• 101710140363 ICP47 protein Proteins 0.000 description 1
• 101710096421 Iduronate 2-sulfatase Proteins 0.000 description 1
• 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
• 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
• 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 1
• 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 1
• 101710180095 Inositol-1-monophosphatase Proteins 0.000 description 1
• 102000002227 Interferon Type I Human genes 0.000 description 1
• 108010014726 Interferon Type I Proteins 0.000 description 1
• 102100026720 Interferon beta Human genes 0.000 description 1
• 102100037850 Interferon gamma Human genes 0.000 description 1
• 108010079944 Interferon-alpha2b Proteins 0.000 description 1
• 108090000467 Interferon-beta Proteins 0.000 description 1
• 102000008070 Interferon-gamma Human genes 0.000 description 1
• 102100039953 Interferon-induced protein 44-like Human genes 0.000 description 1
• 102000013462 Interleukin-12 Human genes 0.000 description 1
• 108010065805 Interleukin-12 Proteins 0.000 description 1
• 102000004889 Interleukin-6 Human genes 0.000 description 1
• 108090001005 Interleukin-6 Proteins 0.000 description 1
• 102000015696 Interleukins Human genes 0.000 description 1
• 108010063738 Interleukins Proteins 0.000 description 1
• 102000037862 Ion Transporter Human genes 0.000 description 1
• 108091006671 Ion Transporter Proteins 0.000 description 1
• 206010023126 Jaundice Diseases 0.000 description 1
• KJHKTHWMRKYKJE-SUGCFTRWSA-N Kaletra Chemical compound N1([C@@H](C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC=2C=CC=CC=2)NC(=O)COC=2C(=CC=CC=2C)C)CC=2C=CC=CC=2)CCCNC1=O KJHKTHWMRKYKJE-SUGCFTRWSA-N 0.000 description 1
• AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
• 239000002211 L-ascorbic acid Substances 0.000 description 1
• 235000000069 L-ascorbic acid Nutrition 0.000 description 1
• AEMOLEFTQBMNLQ-HNFCZKTMSA-N L-idopyranuronic acid Chemical compound OC1O[C@@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-HNFCZKTMSA-N 0.000 description 1
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
• 241000288904 Lemur Species 0.000 description 1
• 108090000856 Lyases Proteins 0.000 description 1
• 102000004317 Lyases Human genes 0.000 description 1
• 108020002496 Lysophospholipase Proteins 0.000 description 1
• 102100025169 Max-binding protein MNT Human genes 0.000 description 1
• 206010027476 Metastases Diseases 0.000 description 1
• 241001465754 Metazoa Species 0.000 description 1
• BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 1
• 241001015606 Microsoma Species 0.000 description 1
• 241001529936 Murinae Species 0.000 description 1
• 101100023508 Mus musculus Mlec gene Proteins 0.000 description 1
• DEFJQIDDEAULHB-UHFFFAOYSA-N N-D-alanyl-D-alanine Natural products CC(N)C(=O)NC(C)C(O)=O DEFJQIDDEAULHB-UHFFFAOYSA-N 0.000 description 1
• CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
• 206010028813 Nausea Diseases 0.000 description 1
• 101710165986 Negative regulator of transcription Proteins 0.000 description 1
• 206010028980 Neoplasm Diseases 0.000 description 1
• 108090000189 Neuropeptides Proteins 0.000 description 1
• 102000003797 Neuropeptides Human genes 0.000 description 1
• 239000000020 Nitrocellulose Substances 0.000 description 1
• 101800001020 Non-structural protein 4A Proteins 0.000 description 1
• 108091092724 Noncoding DNA Proteins 0.000 description 1
• 108091093105 Nuclear DNA Proteins 0.000 description 1
• 102000007999 Nuclear Proteins Human genes 0.000 description 1
• 108010089610 Nuclear Proteins Proteins 0.000 description 1
• 101710163270 Nuclease Proteins 0.000 description 1
• 108091028043 Nucleic acid sequence Proteins 0.000 description 1
• 108091005461 Nucleic proteins Proteins 0.000 description 1
• 102000008021 Nucleoside-Triphosphatase Human genes 0.000 description 1
• 108010075285 Nucleoside-Triphosphatase Proteins 0.000 description 1
• 102000003832 Nucleotidyltransferases Human genes 0.000 description 1
• 108090000119 Nucleotidyltransferases Proteins 0.000 description 1
• 101710173384 Nus factor SuhB Proteins 0.000 description 1
• 102000043276 Oncogene Human genes 0.000 description 1
• AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
• UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
• 102000004132 Ornithine aminotransferases Human genes 0.000 description 1
• 108090000691 Ornithine aminotransferases Proteins 0.000 description 1
• 241000282579 Pan Species 0.000 description 1
• 229940122344 Peptidase inhibitor Drugs 0.000 description 1
• 108010022678 Phosphofructokinase-2 Proteins 0.000 description 1
• 108010089430 Phosphoproteins Proteins 0.000 description 1
• 102000007982 Phosphoproteins Human genes 0.000 description 1
• 102000013566 Plasminogen Human genes 0.000 description 1
• 108010051456 Plasminogen Proteins 0.000 description 1
• NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
• 102000006010 Protein Disulfide-Isomerase Human genes 0.000 description 1
• 108010029485 Protein Isoforms Proteins 0.000 description 1
• 102000001708 Protein Isoforms Human genes 0.000 description 1
• 229940116193 Protein phosphatase inhibitor Drugs 0.000 description 1
• 108010067787 Proteoglycans Proteins 0.000 description 1
• 101710113809 Putative Nus factor SuhB Proteins 0.000 description 1
• NGVDGCNFYWLIFO-UHFFFAOYSA-N Pyridoxal phosphate Natural products CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 1
• 102100029143 RNA 3'-terminal phosphate cyclase Human genes 0.000 description 1
• 102000009572 RNA Polymerase II Human genes 0.000 description 1
• 108010009460 RNA Polymerase II Proteins 0.000 description 1
• 230000006819 RNA synthesis Effects 0.000 description 1
• 101100222379 Rattus norvegicus Cxcl10 gene Proteins 0.000 description 1
• 108010012770 Rebetron Proteins 0.000 description 1
• 102100040756 Rhodopsin Human genes 0.000 description 1
• 108090000820 Rhodopsin Proteins 0.000 description 1
• 108010083644 Ribonucleases Proteins 0.000 description 1
• 102000006382 Ribonucleases Human genes 0.000 description 1
• MEFKEPWMEQBLKI-AIRLBKTGSA-N S-adenosyl-L-methioninate Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H](N)C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-N 0.000 description 1
• 101100049541 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) VPS9 gene Proteins 0.000 description 1
• 101710113029 Serine/threonine-protein kinase Proteins 0.000 description 1
• 101150040974 Set gene Proteins 0.000 description 1
• 102000039471 Small Nuclear RNA Human genes 0.000 description 1
• 108020004688 Small Nuclear RNA Proteins 0.000 description 1
• FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
• 102100038803 Somatotropin Human genes 0.000 description 1
• 229920002472 Starch Polymers 0.000 description 1
• 101000870438 Streptococcus gordonii UDP-N-acetylglucosamine-peptide N-acetylglucosaminyltransferase stabilizing protein GtfB Proteins 0.000 description 1
• 238000000692 Student's t-test Methods 0.000 description 1
• 102000005262 Sulfatase Human genes 0.000 description 1
• QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
• 102000002932 Thiolase Human genes 0.000 description 1
• 108060008225 Thiolase Proteins 0.000 description 1
• 108010046075 Thymosin Proteins 0.000 description 1
• 102000007501 Thymosin Human genes 0.000 description 1
• 102100021386 Trans-acting T-cell-specific transcription factor GATA-3 Human genes 0.000 description 1
• 230000010632 Transcription Factor Activity Effects 0.000 description 1
• 102000012883 Tumor Necrosis Factor Ligand Superfamily Member 14 Human genes 0.000 description 1
• 108010065158 Tumor Necrosis Factor Ligand Superfamily Member 14 Proteins 0.000 description 1
• 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 1
• 102100040247 Tumor necrosis factor Human genes 0.000 description 1
• 102000014384 Type C Phospholipases Human genes 0.000 description 1
• 108010079194 Type C Phospholipases Proteins 0.000 description 1
• 101710098414 Tyrosine-protein phosphatase Proteins 0.000 description 1
• 102000006275 Ubiquitin-Protein Ligases Human genes 0.000 description 1
• 108010083111 Ubiquitin-Protein Ligases Proteins 0.000 description 1
• 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
• 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
• 102100039098 Vacuolar protein sorting-associated protein 72 homolog Human genes 0.000 description 1
• 101000645119 Vibrio campbellii (strain ATCC BAA-1116 / BB120) Nucleotide-binding protein VIBHAR_03667 Proteins 0.000 description 1
• 108010067390 Viral Proteins Proteins 0.000 description 1
• 108020000999 Viral RNA Proteins 0.000 description 1
• 108010047118 Wnt Receptors Proteins 0.000 description 1
• 102000006757 Wnt Receptors Human genes 0.000 description 1
• 210000001766 X chromosome Anatomy 0.000 description 1
• 101000647994 Xenopus laevis Signal transducer and activator of transcription 3.1 Proteins 0.000 description 1
• 210000002593 Y chromosome Anatomy 0.000 description 1
• 150000007513 acids Chemical class 0.000 description 1
• 230000003213 activating effect Effects 0.000 description 1
• 231100000354 acute hepatitis Toxicity 0.000 description 1
• 230000004658 acute-phase response Effects 0.000 description 1
• 102000019997 adhesion receptor Human genes 0.000 description 1
• 108010013985 adhesion receptor Proteins 0.000 description 1
• 108010056243 alanylalanine Proteins 0.000 description 1
• 108010080374 albuferon Proteins 0.000 description 1
• 125000003158 alcohol group Chemical group 0.000 description 1
• DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 description 1
• 229960003805 amantadine Drugs 0.000 description 1
• 229960001830 amprenavir Drugs 0.000 description 1
• YMARZQAQMVYCKC-OEMFJLHTSA-N amprenavir Chemical compound C([C@@H]([C@H](O)CN(CC(C)C)S(=O)(=O)C=1C=CC(N)=CC=1)NC(=O)O[C@@H]1COCC1)C1=CC=CC=C1 YMARZQAQMVYCKC-OEMFJLHTSA-N 0.000 description 1
• 230000019552 anatomical structure morphogenesis Effects 0.000 description 1
• 230000001028 anti-proliverative effect Effects 0.000 description 1
• 230000000798 anti-retroviral effect Effects 0.000 description 1
• 230000000890 antigenic effect Effects 0.000 description 1
• 230000001640 apoptogenic effect Effects 0.000 description 1
• 230000004596 appetite loss Effects 0.000 description 1
• 229960005070 ascorbic acid Drugs 0.000 description 1
• 125000004429 atom Chemical group 0.000 description 1
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
• 230000037444 atrophy Effects 0.000 description 1
• 239000005441 aurora Substances 0.000 description 1
• 230000004900 autophagic degradation Effects 0.000 description 1
• 230000002886 autophagic effect Effects 0.000 description 1
• IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
• 239000012472 biological sample Substances 0.000 description 1
• 230000005540 biological transmission Effects 0.000 description 1
• 238000005460 biophysical method Methods 0.000 description 1
• 229960002685 biotin Drugs 0.000 description 1
• 235000020958 biotin Nutrition 0.000 description 1
• 239000011616 biotin Substances 0.000 description 1
• 208000002352 blister Diseases 0.000 description 1
• 230000023555 blood coagulation Effects 0.000 description 1
• 210000004556 brain Anatomy 0.000 description 1
• 229910052793 cadmium Inorganic materials 0.000 description 1
• BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
• 235000019827 calcium polyphosphate Nutrition 0.000 description 1
• 238000004422 calculation algorithm Methods 0.000 description 1
• 102000006783 calponin Human genes 0.000 description 1
• 108010086826 calponin Proteins 0.000 description 1
• 238000005251 capillar electrophoresis Methods 0.000 description 1
• 229910052799 carbon Inorganic materials 0.000 description 1
• 239000012876 carrier material Substances 0.000 description 1
• 239000005018 casein Substances 0.000 description 1
• BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
• 235000021240 caseins Nutrition 0.000 description 1
• 150000001768 cations Chemical class 0.000 description 1
• 108010051348 cdc42 GTP-Binding Protein Proteins 0.000 description 1
• 238000004113 cell culture Methods 0.000 description 1
• 230000030833 cell death Effects 0.000 description 1
• 210000002421 cell wall Anatomy 0.000 description 1
• 229940106189 ceramide Drugs 0.000 description 1
• ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
• 238000012512 characterization method Methods 0.000 description 1
• 238000002512 chemotherapy Methods 0.000 description 1
• 108091006090 chromatin-associated proteins Proteins 0.000 description 1
• 208000020403 chronic hepatitis C virus infection Diseases 0.000 description 1
• 229960001380 cimetidine Drugs 0.000 description 1
• CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 description 1
• 230000002060 circadian Effects 0.000 description 1
• 235000020971 citrus fruits Nutrition 0.000 description 1
• 238000003759 clinical diagnosis Methods 0.000 description 1
• 238000010367 cloning Methods 0.000 description 1
• RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 1
• 239000005516 coenzyme A Substances 0.000 description 1
• 229940093530 coenzyme a Drugs 0.000 description 1
• 238000004590 computer program Methods 0.000 description 1
• 238000013270 controlled release Methods 0.000 description 1
• 150000004696 coordination complex Chemical class 0.000 description 1
• 229910052802 copper Inorganic materials 0.000 description 1
• 239000010949 copper Substances 0.000 description 1
• 230000027326 copulation Effects 0.000 description 1
• 230000008878 coupling Effects 0.000 description 1
• 238000010168 coupling process Methods 0.000 description 1
• 238000005859 coupling reaction Methods 0.000 description 1
• 150000001944 cysteine derivatives Chemical class 0.000 description 1
• 230000003436 cytoskeletal effect Effects 0.000 description 1
• 230000001086 cytosolic effect Effects 0.000 description 1
• GYOZYWVXFNDGLU-XLPZGREQSA-N dTMP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)C1 GYOZYWVXFNDGLU-XLPZGREQSA-N 0.000 description 1
• 230000006378 damage Effects 0.000 description 1
• 238000007405 data analysis Methods 0.000 description 1
• 230000034994 death Effects 0.000 description 1
• 231100000517 death Toxicity 0.000 description 1
• 230000003247 decreasing effect Effects 0.000 description 1
• 229960005319 delavirdine Drugs 0.000 description 1
• KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 1
• 238000001784 detoxification Methods 0.000 description 1
• 238000007435 diagnostic evaluation Methods 0.000 description 1
• 239000010432 diamond Substances 0.000 description 1
• 235000005911 diet Nutrition 0.000 description 1
• 230000037213 diet Effects 0.000 description 1
• 239000001177 diphosphate Substances 0.000 description 1
• XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
• 235000011180 diphosphates Nutrition 0.000 description 1
• 231100000676 disease causative agent Toxicity 0.000 description 1
• 230000032671 dosage compensation Effects 0.000 description 1
• 230000036267 drug metabolism Effects 0.000 description 1
• 239000012636 effector Substances 0.000 description 1
• 238000001962 electrophoresis Methods 0.000 description 1
• 239000003623 enhancer Substances 0.000 description 1
• 244000309457 enveloped RNA virus Species 0.000 description 1
• 238000006911 enzymatic reaction Methods 0.000 description 1
• 229960003276 erythromycin Drugs 0.000 description 1
• 150000002148 esters Chemical class 0.000 description 1
• 201000010934 exostosis Diseases 0.000 description 1
• 238000002474 experimental method Methods 0.000 description 1
• 210000002744 extracellular matrix Anatomy 0.000 description 1
• 210000001723 extracellular space Anatomy 0.000 description 1
• 150000004665 fatty acids Chemical class 0.000 description 1
• 230000002349 favourable effect Effects 0.000 description 1
• 230000001605 fetal effect Effects 0.000 description 1
• RFHAOTPXVQNOHP-UHFFFAOYSA-N fluconazole Chemical compound C1=NC=NN1CC(C=1C(=CC(F)=CC=1)F)(O)CN1C=NC=N1 RFHAOTPXVQNOHP-UHFFFAOYSA-N 0.000 description 1
• 229960004884 fluconazole Drugs 0.000 description 1
• 229960002464 fluoxetine Drugs 0.000 description 1
• CJOFXWAVKWHTFT-XSFVSMFZSA-N fluvoxamine Chemical compound COCCCC\C(=N/OCCN)C1=CC=C(C(F)(F)F)C=C1 CJOFXWAVKWHTFT-XSFVSMFZSA-N 0.000 description 1
• 229960004038 fluvoxamine Drugs 0.000 description 1
• 102000006815 folate receptor Human genes 0.000 description 1
• 108020005243 folate receptor Proteins 0.000 description 1
• 229960003142 fosamprenavir Drugs 0.000 description 1
• MLBVMOWEQCZNCC-OEMFJLHTSA-N fosamprenavir Chemical compound C([C@@H]([C@H](OP(O)(O)=O)CN(CC(C)C)S(=O)(=O)C=1C=CC(N)=CC=1)NC(=O)O[C@@H]1COCC1)C1=CC=CC=C1 MLBVMOWEQCZNCC-OEMFJLHTSA-N 0.000 description 1
• 230000004927 fusion Effects 0.000 description 1
• 238000003500 gene array Methods 0.000 description 1
• 238000003633 gene expression assay Methods 0.000 description 1
• 238000001415 gene therapy Methods 0.000 description 1
• 229930182478 glucoside Natural products 0.000 description 1
• 150000008131 glucosides Chemical class 0.000 description 1
• 150000004676 glycans Chemical class 0.000 description 1
• 125000003147 glycosyl group Chemical group 0.000 description 1
• 210000002288 golgi apparatus Anatomy 0.000 description 1
• 239000008187 granular material Substances 0.000 description 1
• 230000012010 growth Effects 0.000 description 1
• 239000000122 growth hormone Substances 0.000 description 1
• 210000002443 helper t lymphocyte Anatomy 0.000 description 1
• 230000002440 hepatic effect Effects 0.000 description 1
• 238000007417 hierarchical cluster analysis Methods 0.000 description 1
• 238000004128 high performance liquid chromatography Methods 0.000 description 1
• 108010079916 homocysteinase Proteins 0.000 description 1
• 229920001519 homopolymer Polymers 0.000 description 1
• 230000003054 hormonal effect Effects 0.000 description 1
• 239000005556 hormone Substances 0.000 description 1
• 229940088597 hormone Drugs 0.000 description 1
• 230000028996 humoral immune response Effects 0.000 description 1
• 230000008348 humoral response Effects 0.000 description 1
• 229930195733 hydrocarbon Natural products 0.000 description 1
• 150000002430 hydrocarbons Chemical class 0.000 description 1
• GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
• 230000005965 immune activity Effects 0.000 description 1
• 210000002865 immune cell Anatomy 0.000 description 1
• 238000003018 immunoassay Methods 0.000 description 1
• 229940072221 immunoglobulins Drugs 0.000 description 1
• 238000011534 incubation Methods 0.000 description 1
• 229960001936 indinavir Drugs 0.000 description 1
• CBVCZFGXHXORBI-PXQQMZJSSA-N indinavir Chemical compound C([C@H](N(CC1)C[C@@H](O)C[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H]2C3=CC=CC=C3C[C@H]2O)C(=O)NC(C)(C)C)N1CC1=CC=CN=C1 CBVCZFGXHXORBI-PXQQMZJSSA-N 0.000 description 1
• 230000006882 induction of apoptosis Effects 0.000 description 1
• 229940090438 infergen Drugs 0.000 description 1
• 206010022000 influenza Diseases 0.000 description 1
• 238000001802 infusion Methods 0.000 description 1
• 230000000977 initiatory effect Effects 0.000 description 1
• 238000002347 injection Methods 0.000 description 1
• 239000007924 injection Substances 0.000 description 1
• 102000006029 inositol monophosphatase Human genes 0.000 description 1
• 230000010354 integration Effects 0.000 description 1
• 229950000038 interferon alfa Drugs 0.000 description 1
• 229960003521 interferon alfa-2a Drugs 0.000 description 1
• 229960004061 interferon alfa-n1 Drugs 0.000 description 1
• 108010010648 interferon alfacon-1 Proteins 0.000 description 1
• 108010085650 interferon gamma receptor Proteins 0.000 description 1
• 239000002799 interferon inducing agent Substances 0.000 description 1
• 229940117681 interleukin-12 Drugs 0.000 description 1
• 229940100601 interleukin-6 Drugs 0.000 description 1
• 108010079515 intersectin 1 Proteins 0.000 description 1
• 230000031146 intracellular signal transduction Effects 0.000 description 1
• 230000010189 intracellular transport Effects 0.000 description 1
• 238000002955 isolation Methods 0.000 description 1
• 229960004130 itraconazole Drugs 0.000 description 1
• 102000010404 kinase activity proteins Human genes 0.000 description 1
• 108040005184 kinase activity proteins Proteins 0.000 description 1
• 238000007834 ligase chain reaction Methods 0.000 description 1
• 230000000670 limiting effect Effects 0.000 description 1
• 108700041430 link Proteins 0.000 description 1
• 235000019626 lipase activity Nutrition 0.000 description 1
• 230000008604 lipoprotein metabolism Effects 0.000 description 1
• 238000012317 liver biopsy Methods 0.000 description 1
• 208000018191 liver inflammation Diseases 0.000 description 1
• 238000011068 loading method Methods 0.000 description 1
• 230000007774 longterm Effects 0.000 description 1
• 229960004525 lopinavir Drugs 0.000 description 1
• 235000021266 loss of appetite Nutrition 0.000 description 1
• 208000019017 loss of appetite Diseases 0.000 description 1
• 210000004072 lung Anatomy 0.000 description 1
• 230000002132 lysosomal effect Effects 0.000 description 1
• 108010026228 mRNA guanylyltransferase Proteins 0.000 description 1
• 210000002540 macrophage Anatomy 0.000 description 1
• 238000012423 maintenance Methods 0.000 description 1
• 230000003211 malignant effect Effects 0.000 description 1
• 238000004949 mass spectrometry Methods 0.000 description 1
• 239000000463 material Substances 0.000 description 1
• 238000010297 mechanical methods and process Methods 0.000 description 1
• 230000009061 membrane transport Effects 0.000 description 1
• 210000003716 mesoderm Anatomy 0.000 description 1
• 239000002207 metabolite Substances 0.000 description 1
• 239000003475 metalloproteinase inhibitor Substances 0.000 description 1
• 230000009401 metastasis Effects 0.000 description 1
• 229930182817 methionine Natural products 0.000 description 1
• 230000011987 methylation Effects 0.000 description 1
• 238000007069 methylation reaction Methods 0.000 description 1
• 229960002509 miconazole Drugs 0.000 description 1
• HPNSFSBZBAHARI-UHFFFAOYSA-N micophenolic acid Natural products OC1=C(CC=C(C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-UHFFFAOYSA-N 0.000 description 1
• 230000017205 mitotic cell cycle checkpoint Effects 0.000 description 1
• 230000000394 mitotic effect Effects 0.000 description 1
• 239000003068 molecular probe Substances 0.000 description 1
• 210000005087 mononuclear cell Anatomy 0.000 description 1
• 150000004712 monophosphates Chemical group 0.000 description 1
• HPNSFSBZBAHARI-RUDMXATFSA-N mycophenolic acid Chemical compound OC1=C(C\C=C(/C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-RUDMXATFSA-N 0.000 description 1
• 229960000951 mycophenolic acid Drugs 0.000 description 1
• 108700003805 myo-inositol-1 (or 4)-monophosphatase Proteins 0.000 description 1
• OHDXDNUPVVYWOV-UHFFFAOYSA-N n-methyl-1-(2-naphthalen-1-ylsulfanylphenyl)methanamine Chemical compound CNCC1=CC=CC=C1SC1=CC=CC2=CC=CC=C12 OHDXDNUPVVYWOV-UHFFFAOYSA-N 0.000 description 1
• 230000008693 nausea Effects 0.000 description 1
• VRBKIVRKKCLPHA-UHFFFAOYSA-N nefazodone Chemical compound O=C1N(CCOC=2C=CC=CC=2)C(CC)=NN1CCCN(CC1)CCN1C1=CC=CC(Cl)=C1 VRBKIVRKKCLPHA-UHFFFAOYSA-N 0.000 description 1
• 229960001800 nefazodone Drugs 0.000 description 1
• 229960000884 nelfinavir Drugs 0.000 description 1
• QAGYKUNXZHXKMR-HKWSIXNMSA-N nelfinavir Chemical compound CC1=C(O)C=CC=C1C(=O)N[C@H]([C@H](O)CN1[C@@H](C[C@@H]2CCCC[C@@H]2C1)C(=O)NC(C)(C)C)CSC1=CC=CC=C1 QAGYKUNXZHXKMR-HKWSIXNMSA-N 0.000 description 1
• VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
• 229920001220 nitrocellulos Polymers 0.000 description 1
• 229910052757 nitrogen Inorganic materials 0.000 description 1
• 108091027963 non-coding RNA Proteins 0.000 description 1
• 102000042567 non-coding RNA Human genes 0.000 description 1
• 238000007474 nonparametric Mann- Whitney U test Methods 0.000 description 1
• 125000002796 nucleotidyl group Chemical group 0.000 description 1
• 238000005457 optimization Methods 0.000 description 1
• 210000003463 organelle Anatomy 0.000 description 1
• 229960003104 ornithine Drugs 0.000 description 1
• 230000003647 oxidation Effects 0.000 description 1
• 230000036542 oxidative stress Effects 0.000 description 1
• 239000001301 oxygen Substances 0.000 description 1
• 229910052760 oxygen Inorganic materials 0.000 description 1
• 125000004430 oxygen atom Chemical group O* 0.000 description 1
• 229940014662 pantothenate Drugs 0.000 description 1
• 235000019161 pantothenic acid Nutrition 0.000 description 1
• 239000011713 pantothenic acid Substances 0.000 description 1
• 229960003930 peginterferon alfa-2a Drugs 0.000 description 1
• 229960003931 peginterferon alfa-2b Drugs 0.000 description 1
• 229940106366 pegintron Drugs 0.000 description 1
• 239000000816 peptidomimetic Substances 0.000 description 1
• 230000002093 peripheral effect Effects 0.000 description 1
• 230000002688 persistence Effects 0.000 description 1
• 230000000144 pharmacologic effect Effects 0.000 description 1
• 150000003905 phosphatidylinositols Chemical class 0.000 description 1
• 239000003934 phosphoprotein phosphatase inhibitor Substances 0.000 description 1
• 230000036470 plasma concentration Effects 0.000 description 1
• 230000035409 positive regulation of cell proliferation Effects 0.000 description 1
• 230000009098 positive regulation of endothelial cell differentiation Effects 0.000 description 1
• 230000035935 pregnancy Effects 0.000 description 1
• 230000000750 progressive effect Effects 0.000 description 1
• 230000035755 proliferation Effects 0.000 description 1
• 230000002035 prolonged effect Effects 0.000 description 1
• 230000000069 prophylactic effect Effects 0.000 description 1
• 238000011321 prophylaxis Methods 0.000 description 1
• 230000010069 protein adhesion Effects 0.000 description 1
• 238000002331 protein detection Methods 0.000 description 1
• 108020003519 protein disulfide isomerase Proteins 0.000 description 1
• 229940121649 protein inhibitor Drugs 0.000 description 1
• 239000012268 protein inhibitor Substances 0.000 description 1
• 230000020978 protein processing Effects 0.000 description 1
• 238000000734 protein sequencing Methods 0.000 description 1
• 230000029983 protein stabilization Effects 0.000 description 1
• 238000001243 protein synthesis Methods 0.000 description 1
• 238000009163 protein therapy Methods 0.000 description 1
• 238000000746 purification Methods 0.000 description 1
• 230000001696 purinergic effect Effects 0.000 description 1
• 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 description 1
• 239000011589 pyridoxal 5'-phosphate Substances 0.000 description 1
• 229960001327 pyridoxal phosphate Drugs 0.000 description 1
• 102000016914 ras Proteins Human genes 0.000 description 1
• 108010014186 ras Proteins Proteins 0.000 description 1
• 230000000306 recurrent effect Effects 0.000 description 1
• 230000025915 regulation of apoptotic process Effects 0.000 description 1
• 230000009703 regulation of cell differentiation Effects 0.000 description 1
• 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
• 230000010076 replication Effects 0.000 description 1
• 238000011160 research Methods 0.000 description 1
• 108091008146 restriction endonucleases Proteins 0.000 description 1
• 230000000717 retained effect Effects 0.000 description 1
• 238000003757 reverse transcription PCR Methods 0.000 description 1
• 230000033764 rhythmic process Effects 0.000 description 1
• 230000001020 rhythmical effect Effects 0.000 description 1
• 210000003705 ribosome Anatomy 0.000 description 1
• 238000012502 risk assessment Methods 0.000 description 1
• 229960001852 saquinavir Drugs 0.000 description 1
• QWAXKHKRTORLEM-UGJKXSETSA-N saquinavir Chemical compound C([C@@H]([C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)C=1N=C2C=CC=CC2=CC=1)C1=CC=CC=C1 QWAXKHKRTORLEM-UGJKXSETSA-N 0.000 description 1
• 108020002447 serine esterase Proteins 0.000 description 1
• 102000005428 serine esterase Human genes 0.000 description 1
• 230000000405 serological effect Effects 0.000 description 1
• 229960002073 sertraline Drugs 0.000 description 1
• VGKDLMBJGBXTGI-SJCJKPOMSA-N sertraline Chemical compound C1([C@@H]2CC[C@@H](C3=CC=CC=C32)NC)=CC=C(Cl)C(Cl)=C1 VGKDLMBJGBXTGI-SJCJKPOMSA-N 0.000 description 1
• 210000002966 serum Anatomy 0.000 description 1
• 238000007493 shaping process Methods 0.000 description 1
• 230000029003 signal transducer activity Effects 0.000 description 1
• 229940043517 specific immunoglobulins Drugs 0.000 description 1
• 238000010186 staining Methods 0.000 description 1
• 235000019698 starch Nutrition 0.000 description 1
• 239000008107 starch Substances 0.000 description 1
• 238000007619 statistical method Methods 0.000 description 1
• 150000003431 steroids Chemical class 0.000 description 1
• 210000003699 striated muscle Anatomy 0.000 description 1
• 238000007920 subcutaneous administration Methods 0.000 description 1
• 238000006467 substitution reaction Methods 0.000 description 1
• 108060007951 sulfatase Proteins 0.000 description 1
• 150000003462 sulfoxides Chemical class 0.000 description 1
• 229910021653 sulphate ion Inorganic materials 0.000 description 1
• 230000000946 synaptic effect Effects 0.000 description 1
• 230000007474 system interaction Effects 0.000 description 1
• IQFYYKKMVGJFEH-CSMHCCOUSA-N telbivudine Chemical compound O=C1NC(=O)C(C)=CN1[C@H]1O[C@@H](CO)[C@H](O)C1 IQFYYKKMVGJFEH-CSMHCCOUSA-N 0.000 description 1
• 229960005311 telbivudine Drugs 0.000 description 1
• 229940124597 therapeutic agent Drugs 0.000 description 1
• 238000011285 therapeutic regimen Methods 0.000 description 1
• LCJVIYPJPCBWKS-NXPQJCNCSA-N thymosin Chemical compound SC[C@@H](N)C(=O)N[C@H](CO)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CO)C(=O)N[C@H](CO)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H]([C@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@H](CCC(O)=O)C(O)=O LCJVIYPJPCBWKS-NXPQJCNCSA-N 0.000 description 1
• 102000004217 thyroid hormone receptors Human genes 0.000 description 1
• 108090000721 thyroid hormone receptors Proteins 0.000 description 1
• 210000001519 tissue Anatomy 0.000 description 1
• 229960000707 tobramycin Drugs 0.000 description 1
• NLVFBUXFDBBNBW-PBSUHMDJSA-S tobramycin(5+) Chemical compound [NH3+][C@@H]1C[C@H](O)[C@@H](C[NH3+])O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H]([NH3+])[C@H](O)[C@@H](CO)O2)O)[C@H]([NH3+])C[C@@H]1[NH3+] NLVFBUXFDBBNBW-PBSUHMDJSA-S 0.000 description 1
• 108091006106 transcriptional activators Proteins 0.000 description 1
• 108091006107 transcriptional repressors Proteins 0.000 description 1
• 230000007704 transition Effects 0.000 description 1
• 230000007723 transport mechanism Effects 0.000 description 1
• 150000003626 triacylglycerols Chemical class 0.000 description 1
• 230000001960 triggered effect Effects 0.000 description 1
• 210000002993 trophoblast Anatomy 0.000 description 1
• 229960004799 tryptophan Drugs 0.000 description 1
• 102000003298 tumor necrosis factor receptor Human genes 0.000 description 1
• 210000002700 urine Anatomy 0.000 description 1
• 229960005356 urokinase Drugs 0.000 description 1
• 238000012795 verification Methods 0.000 description 1
• 230000006490 viral transcription Effects 0.000 description 1
• 230000016776 visual perception Effects 0.000 description 1
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
• 101150000251 xiap gene Proteins 0.000 description 1